First Clinicopathologic Evidence of a Non–PSMA-Related Uptake Mechanism for 68Ga-PSMA-11 in Salivary Glands

Niels J. Rupp; Christoph A. Umbricht; Daniele A. Pizzuto; Daniela Lenggenhager; Antonia Töpfer; Julian Müller; Urs J. Muehlematter; Daniela A. Ferraro; Michael Messerli; Grégoire B. Morand; Gerhard F. Huber; Daniel Eberli; Roger Schibli; Cristina Müller; Irene A. Burger

doi:10.2967/jnumed.118.222307

Research ArticleTheranostics

First Clinicopathologic Evidence of a Non–PSMA-Related Uptake Mechanism for ⁶⁸Ga-PSMA-11 in Salivary Glands

Niels J. Rupp, Christoph A. Umbricht, Daniele A. Pizzuto, Daniela Lenggenhager, Antonia Töpfer, Julian Müller, Urs J. Muehlematter, Daniela A. Ferraro, Michael Messerli, Grégoire B. Morand, Gerhard F. Huber, Daniel Eberli, Roger Schibli, Cristina Müller and Irene A. Burger

Journal of Nuclear Medicine September 2019, 60 (9) 1270-1276; DOI: https://doi.org/10.2967/jnumed.118.222307

Niels J. Rupp

1Department of Pathology and Molecular Pathology, University Hospital Zürich, University of Zürich, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Christoph A. Umbricht

2Center for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institute, Villigen-PSI, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Daniele A. Pizzuto

3Department of Nuclear Medicine, University Hospital Zürich, University of Zürich, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Daniela Lenggenhager

1Department of Pathology and Molecular Pathology, University Hospital Zürich, University of Zürich, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Antonia Töpfer

1Department of Pathology and Molecular Pathology, University Hospital Zürich, University of Zürich, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Julian Müller

3Department of Nuclear Medicine, University Hospital Zürich, University of Zürich, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Urs J. Muehlematter

3Department of Nuclear Medicine, University Hospital Zürich, University of Zürich, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Daniela A. Ferraro

3Department of Nuclear Medicine, University Hospital Zürich, University of Zürich, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Michael Messerli

3Department of Nuclear Medicine, University Hospital Zürich, University of Zürich, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Grégoire B. Morand

4Department of Otorhinolaryngology - Head and Neck Surgery, University Hospital Zürich, University of Zürich, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Gerhard F. Huber

5Department of Otorhinolaryngology - Head and Neck Surgery, Kantonsspital St. Gallen, Switzerland; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Daniel Eberli

6Department of Urology, University Hospital Zürich, University of Zürich, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Roger Schibli

2Center for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institute, Villigen-PSI, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Cristina Müller

2Center for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institute, Villigen-PSI, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Irene A. Burger

3Department of Nuclear Medicine, University Hospital Zürich, University of Zürich, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 60, Issue 9

September 1, 2019

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following First Clinicopathologic Evidence of a Non–PSMA-Related Uptake Mechanism for 68Ga-PSMA-11 in Salivary Glands

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

First Clinicopathologic Evidence of a Non–PSMA-Related Uptake Mechanism for ⁶⁸Ga-PSMA-11 in Salivary Glands

Journal of Nuclear Medicine Sep 2019, 60 (9) 1270-1276; DOI: 10.2967/jnumed.118.222307

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

First Clinicopathologic Evidence of a Non–PSMA-Related Uptake Mechanism for ⁶⁸Ga-PSMA-11 in Salivary Glands

Journal of Nuclear Medicine Sep 2019, 60 (9) 1270-1276; DOI: 10.2967/jnumed.118.222307

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

This Month in JNM

PubMed
Google Scholar

Cited By...

No citing articles found.

Google Scholar

Theranostics

¹⁷⁷Lu-Labeled Anticlaudin 6 Monoclonal Antibody for Targeted Therapy in Esophageal Cancer
Terbium-161, a Promising New Theranostic Radionuclide
Association of change in PSMA avid tumor burden during 177Lu-PSMA-617 therapy with overall survival: Should mid-point PET become standard protocol?

Show more Theranostics

Clinical

Addition of ¹³¹I-MIBG to PRRT (⁹⁰Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors
SUVs Are Adequate Measures of Lesional ¹⁸F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden
Hypermetabolism on Pediatric PET Scans of Brain Glucose Metabolism: What Does It Signify?

Show more Clinical

Keywords

prostate cancer
prostate-specific membrane antigen
177Lu-PSMA-617
68Ga-PSMA-11
positron emission tomography
immuno-histochemistry
autoradiography

Main menu

User menu

Search

First Clinicopathologic Evidence of a Non–PSMA-Related Uptake Mechanism for ⁶⁸Ga-PSMA-11 in Salivary Glands

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Theranostics

Clinical

Similar Articles

Keywords